PeptideStack
5.2kquestions
20kanswers
220users

Why did my ferritin move after four weeks on dulaglutide?

Asked 11 May 2026Modified 2 days agoViewed 8.3k times
18

Conditions: ferritin · four weeks · dulaglutide.

I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact.

I want to know whether this is recoverable or whether the honest answer is to write it off.

Should I be treating this as a failure or as noise?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
dulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questions
shareeditfollowflag
MT
askedmarcus_thorbjorn9.4k1611 May 2026
7Same situation here, so I will follow this one. – Dr_Malik_Osei 5 months ago
6Which analyte, and what reference interval did the laboratory print beside it? – h_pergande 4 months ago
add a comment

5 Answers

Accepted answer first, then by votes
28

Accepted answer

4 weeks is 28 days, and the first question about any marker is whether 28 days is long enough for it to have finished moving. Ferritin is an acute-phase reactant as much as an iron store, so it rises with inflammation and falls with intake, and one number cannot separate the two. Against 28 days the marker is at or near the edge of its own settling time, so part of what you are reading is the transition rather than the destination. The second question is the denominator. Weight loss moves plasma volume, muscle mass and intake at once, and several of the markers on a routine panel are ratios with one of those three underneath them. Repeat before interpreting. A single value 28 days in, with no baseline drawn under the same conditions, is a number rather than a change — and nothing here is medical advice.

To be exact about it, this is answerable, and the answer is mostly about which tests rather than how many.

Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

Ordering tests you will not act on generates anxiety and incidental findings, both of which have costs.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
LQ
answered · acceptedlipid_panel_q36k12728 Jun 2026
7Is the assay method stated on your report? Two immunoassays for the same analyte do not agree with each other. – RP_C18 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
23

Answer first: decide what you would do differently for each possible result before you order the panel. Anything that fails that test is a number you will worry about and not act on.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

More usefully, haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Research-use compounds are not approved for human use, and no panel makes that safer.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
DA
answeredDr_Rosalind_Achebe69k14727 Jul 2026
8Worth adding that the collection tube and how long the tourniquet was on move several of these analytes. – Dr_Wren_Halliday 4 months ago
Same experience here, different supplier. – laminar_bench 6 months ago
add a comment
11

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Nothing here is medical advice. If something is out of range and you do not know why, that is a consultation rather than a research project.

Decide the action for each result before you order the test.

edited 28 Jul 2026 by fresh_bac — added the citation requested in comments

shareimprove this answerflag
FB
answeredfresh_bac9.7k165 Jul 2026
9

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Pre-analytical factors — posture, tourniquet time, fasting, sample handling — are the largest source of error in routine biochemistry, well ahead of the analysis itself.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
DK
answeredDr_Sara_Kuusela28k3713 Jun 2026
8

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Reference intervals are conventionally the central ninety-five per cent of a reference population, which is the direct cause of the one-in-twenty out-of-range rate on a healthy panel.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
DB
answeredDr_Signe_Baldursdottir29k276 Jun 2026
7Small correction: eGFR is an estimate derived from creatinine, not a measurement, and the equation used matters. – ellis_thorne 10 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.